Sodium phenylacetate/sodium benzoate: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===[[Inborn errors of metabolism|Hyperammonemia]]=== | |||
*250mg/kg in D10 over 90min; then 250mg/kg/d infusion | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 05:50, 14 August 2019
Administration
- Type:
- Dosage Forms:
- Routes of Administration:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Hyperammonemia
- 250mg/kg in D10 over 90min; then 250mg/kg/d infusion
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: